News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,726 Results
Type
Article (8020)
Company Profile (140)
Press Release (476565)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166761)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52887)
Employer Resources (14)
FDA (9760)
Job Trends (8575)
News (238220)
Policy (17908)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33167)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10376)
Artificial intelligence (320)
ASCO (161)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6964)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3658)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47884)
Collaboration (1246)
Commercialization (3)
Compensation (1468)
Complete response letters (34)
COVID-19 (756)
CRISPR (64)
C-suite (752)
Cystic fibrosis (85)
Data (5656)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73715)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87628)
Executive appointments (704)
FDA (12388)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (921)
Gene editing (126)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9330)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14384)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3153)
Non-profit (849)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41266)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15474)
Phase 2 (21376)
Phase 3 (14406)
Pipeline (7325)
Policy (18)
Postmarket research (1573)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3021)
Recruiting (6)
Regulatory (14827)
Reports (21)
Research institute (594)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Last 7 days (220)
Last 30 days (1536)
Last 365 days (19005)
2026 (12304)
2025 (19257)
2024 (22991)
2023 (26539)
2022 (34590)
2021 (37181)
2020 (33485)
2019 (23262)
2018 (17494)
2017 (18766)
2016 (17919)
2015 (24277)
2014 (21680)
2013 (18137)
2012 (20221)
2011 (20441)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17887)
Australia (2098)
California (11978)
Canada (3147)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24627)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7851)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2623)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (6006)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2254)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4970)
Tennessee (120)
Texas (1940)
United States (38875)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,726 Results for "picis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PICI Invests More Than $1 Million in Five Early Career Researchers Advancing the Future of Cancer Immunotherapy
August 19, 2026
·
5 min read
Press Releases
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study
September 25, 2024
·
5 min read
Business
Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response
Guardant Health, Inc. and the Parker Institute for Cancer Immunotherapy (PICI) today announced a research collaboration agreement to study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment across more than 14 different types of cancer.
April 25, 2023
·
6 min read
Press Releases
Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026
May 24, 2026
·
7 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Aimee Johnson as Chief Marketing Officer
May 6, 2026
·
3 min read
Press Releases
Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026
April 19, 2026
·
5 min read
Press Releases
Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
March 27, 2026
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
February 25, 2026
·
3 min read
Press Releases
Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
January 29, 2026
·
3 min read
1 of 48,473
Next
